Neuralink, the brain-chip interface (BCI) developed by Elon Musk, has made significant progress with its latest implantation into a third human patient. The individual, Bradford G Smith, who shared his experience in a video posted on Monday, is the first non-verbal patient with Amyotrophic Lateral Sclerosis (ALS) to receive the Neuralink BCI. In the video, Smith demonstrates how the BCI allows him to regain control over external devices and communicate using AI technology.
Smith expressed his excitement about being able to communicate primarily through his brain, highlighting the BCI as his primary mode of communication. Prior to receiving the Neuralink implant, Smith relied on eye tracker technology, which limited his communication abilities and mobility. With the BCI, he now has the freedom to interact with external devices and control his computer using a cursor, as showcased in the video.
The video also features an AI-generated version of Smith’s old voice narrating his experience, emphasizing the transformative impact of the BCI on his life. Smith mentions that the BCI has enabled him to leave his house and communicate effectively in various settings, a feat that was challenging with his previous eye tracker technology.
Neuralink’s ongoing studies focus on restoring autonomy to individuals with physical disabilities, particularly those who are paraplegic. The company received approval from the U.S. Food and Drug Administration (FDA) to implant the first BCI in a human patient in May 2023. Since then, Neuralink has successfully implanted BCIs in three patients, including Smith, with plans to expand its studies globally.
In addition to its groundbreaking technology, Neuralink is also making strides in funding and infrastructure development. The company is reportedly targeting a $500 million funding round at a valuation of $8.5 billion, signaling investor confidence in its innovative approach. Furthermore, Neuralink is constructing office buildings near Austin, Texas, with completion expected by May 2025.
Overall, Neuralink’s latest update underscores the promising advancements in BCI technology and its potential to enhance the lives of individuals with neurological conditions. With ongoing research and expansion efforts, Neuralink is poised to revolutionize the field of neurotechnology and empower individuals with disabilities to lead more independent lives.